Nirmatrelvir is a protease inhibitor that stops the SARS-CoV-2 virus from replicating while ritonavir boosts the activity of nirmatrelvir. It is given in a five-day course with three pills taken twice ...

Paxlovid is an antiviral combination therapy that can reduce the risk of COVID-19 causing severe illness, hospitalization and ...

Paxlovid made no significant improvement to long COVID symptoms, including fatigue, brain fog and body aches. The finding “does not rule out” Paxlovid as a therapy, the researchers wrote.

Paxlovid isn't the only antiviral medication for COVID-19. Merck’s Lagevrio is another available pill, though it's proven to be less popular in the U.S. than Paxlovid.

WHAT TO KNOW The antiviral drug Paxlovid dramatically reduces the chance of death and hospitalization for people at high risk of severe COVID-19, but uptake is low, studies have found. Experts say ...

O’Connor said the Paxlovid treatment would continue and the president would keep working. The White House said Wednesday that Biden, 81 years old, had tested positive for Covid-19.

An extended course of Paxlovid appears to help some patients with long COVID, according to a case series by UC San Francisco researchers that suggests this treatment option holds promise for some ...

Tens of thousands of Americans are hospitalized with COVID-19 every week. Thousands die from it every month. And yet, an antiviral treatment proven to lessen the chances of severe outcomes is going… ...

People who took Pfizer’s antiviral treatment Paxlovid shortly after infection saw a 26% lower risk of long Covid compared with those who didn’t, the study said.

By Jen Christensen, CNN Jul 22, 2022 Jul 22, 2022Updated Jul 26, 2024 ...

As Texas and the majority of the country experience a surge in COVID-19 cases, more people testing positive might be seeking out relief through treatment drugs like Paxlovid.